Sung-Nam Lim

775 total citations
36 papers, 262 citations indexed

About

Sung-Nam Lim is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Sung-Nam Lim has authored 36 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Hematology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Sung-Nam Lim's work include Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (7 papers) and Viral-associated cancers and disorders (6 papers). Sung-Nam Lim is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (7 papers) and Viral-associated cancers and disorders (6 papers). Sung-Nam Lim collaborates with scholars based in South Korea, United States and United Arab Emirates. Sung-Nam Lim's co-authors include Joo-Seop Chung, Gyeong‐Won Lee, Won-Sik Lee, Deok‐Hwan Yang, Je‐Hwan Lee, Jung‐Hee Lee, Ho‐Jin Shin, Hye‐kyung Shim, Dae‐Young Kim and Kyoo‐Hyung Lee and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Sung-Nam Lim

32 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung-Nam Lim South Korea 9 100 80 79 51 43 36 262
Hajime Senjo Japan 9 79 0.8× 54 0.7× 49 0.6× 16 0.3× 45 1.0× 31 222
James I. Barnes United States 6 25 0.3× 243 3.0× 75 0.9× 37 0.7× 40 0.9× 10 353
Ali Bukhari United States 9 21 0.2× 206 2.6× 70 0.9× 25 0.5× 45 1.0× 25 297
Chikako Kiyotani Japan 11 24 0.2× 33 0.4× 26 0.3× 68 1.3× 56 1.3× 43 246
Beatriz Aguado Spain 9 127 1.3× 92 1.1× 15 0.2× 11 0.2× 82 1.9× 22 215
Po‐Shen Ko Taiwan 10 87 0.9× 80 1.0× 73 0.9× 12 0.2× 46 1.1× 37 260
Christos Smias Greece 10 169 1.7× 83 1.0× 122 1.5× 46 0.9× 19 0.4× 14 313
Nataliya Kuptsova‐Clarkson United States 9 30 0.3× 61 0.8× 82 1.0× 20 0.4× 37 0.9× 16 234
Ömür Gökmen Sevindik Türkiye 8 85 0.8× 104 1.3× 46 0.6× 29 0.6× 33 0.8× 52 205
Ana Garrido Spain 12 117 1.2× 98 1.2× 36 0.5× 41 0.8× 73 1.7× 26 324

Countries citing papers authored by Sung-Nam Lim

Since Specialization
Citations

This map shows the geographic impact of Sung-Nam Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung-Nam Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung-Nam Lim more than expected).

Fields of papers citing papers by Sung-Nam Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung-Nam Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung-Nam Lim. The network helps show where Sung-Nam Lim may publish in the future.

Co-authorship network of co-authors of Sung-Nam Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Sung-Nam Lim. A scholar is included among the top collaborators of Sung-Nam Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung-Nam Lim. Sung-Nam Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Park, Changhee, Ho Sup Lee, Ka‐Won Kang, et al.. (2024). Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature Communications. 15(1). 2776–2776. 6 indexed citations
3.
Kim, Mihee, Je‐Jung Lee, Chang‐Ki Min, et al.. (2023). Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015). Annals of Hematology. 102(8). 2233–2240. 1 indexed citations
4.
Jeong, Seri, Sangjin Lee, Sung-Nam Lim, et al.. (2023). Incidence and risk factors of opportunistic infections after autologous stem cell transplantation: a nationwide, population-based cohort study in Korea. Scientific Reports. 13(1). 2551–2551. 2 indexed citations
5.
Choi, Hee Eun, et al.. (2020). Comprehensive pulmonary rehabilitation in patients with bronchiolitis obliterans syndrome: A case series. Respiratory Medicine Case Reports. 31. 101161–101161. 2 indexed citations
6.
Park, Sungwoo, Jae‐Cheol Jo, Young Rok, et al.. (2018). Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(3). 149–156. 5 indexed citations
7.
Kim, Yong Kyun, Dong Hwan Lee, Jaehyun Jeon, et al.. (2018). Population Pharmacokinetic Analysis of Meropenem After Intravenous Infusion in Korean Patients With Acute Infections. Clinical Therapeutics. 40(8). 1384–1395. 10 indexed citations
8.
Kim, Eun Kyoung, et al.. (2017). Multiple primary malignancies of laryngeal cancer, small cell lung cancer and squamous cell lung cancer in a patient: how to approach MPMs. BMJ Case Reports. 2017. bcr2016216305–bcr2016216305. 3 indexed citations
9.
Lee, Kyoo‐Hyung, Je‐Hwan Lee, Jung‐Hee Lee, et al.. (2017). Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission. Biology of Blood and Marrow Transplantation. 23(9). 1555–1566. 18 indexed citations
10.
11.
Suh, Cheolwon, Young Rok, Je‐Jung Lee, et al.. (2016). Clinical Features and Survival of Patients With Follicular Lymphoma in Korea. Clinical Lymphoma Myeloma & Leukemia. 16(4). 197–202. 3 indexed citations
12.
Chung, Joo-Seop, et al.. (2016). Tumor necrosis could reflect advanced disease status in patients with diffuse large B cell lymphoma treated with R-CHOP therapy. Annals of Hematology. 96(1). 17–23. 15 indexed citations
13.
Yang, Deok‐Hwan, Gyeong‐Won Lee, Sung-Nam Lim, et al.. (2016). High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era. Leukemia Research. 42. 1–6. 43 indexed citations
14.
Lim, Sung-Nam, Hyesook Han, Sang‐Cheol Lee, et al.. (2015). A Satisfaction Survey on Cancer Pain Management Using a Self-Reporting Pain Assessment Tool. Journal of Palliative Medicine. 18(3). 225–231. 13 indexed citations
15.
Shin, Ho‐Jin, Dok Hyun Yoon, Ho Sup Lee, et al.. (2015). Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients. Experimental Hematology. 44(1). 3–13. 6 indexed citations
16.
Lim, Sung-Nam, Anil K. Pradhan, Rolf F. Barth, et al.. (2014). Tumoricidal activity of low-energy 160-KV versus 6-MV X-rays against platinum-sensitized F98 glioma cells. Journal of Radiation Research. 56(1). 77–89. 10 indexed citations
17.
Han, Joung‐Ho, Sung-Nam Lim, Hye‐Suk Han, et al.. (2013). Acute lymphoblastic leukemia with gastric involvement initially diagnosed by endoscopy and EUS. Gastrointestinal Endoscopy. 78(4). 655–656. 1 indexed citations
18.
Han, Hye‐Suk, Sung-Nam Lim, Young Duck Shin, et al.. (2012). The Effectiveness of a Self-Reporting Bedside Pain Assessment Tool for Oncology Inpatients. Journal of Palliative Medicine. 15(11). 1222–1233. 14 indexed citations
19.
Choi, Yunsuk, Je‐Hwan Lee, Dae‐Young Kim, et al.. (2009). Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia: Role of the NPM1 Mutations May Be Different in Different Races.. Blood. 114(22). 4684–4684.
20.
Lee, Je‐Hwan, Jung‐Hee Lee, Dae‐Young Kim, et al.. (2008). Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia. Leukemia Research. 33(4). 511–517. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hajime Senjo Breakdown of academic impact, for papers by James I. Barnes Breakdown of academic impact, for papers by Ali Bukhari Breakdown of academic impact, for papers by Chikako Kiyotani Breakdown of academic impact, for papers by Beatriz Aguado Breakdown of academic impact, for papers by Po‐Shen Ko Breakdown of academic impact, for papers by Christos Smias Breakdown of academic impact, for papers by Nataliya Kuptsova‐Clarkson Breakdown of academic impact, for papers by Ömür Gökmen Sevindik Breakdown of academic impact, for papers by Ana Garrido
Rankless by CCL
2026